
您的位置:首页 > 医药代理医药代理
高敏肌钙蛋白检测并不能改善急性心梗患者的预后
MIMS医药资讯2020-04-09 09:10:32人已围观
The use of high-sensitivity cardiactroponin assays was not associated with a lower subsequent incidence of myocardial infarction (MI) or cardiovascular death at 1 year, according to results of the High-STEACS trial reported at ESC 2018.
In the study among 48,282 patients (meanage, 61 years; 47 percent women) performed between June 2013 and March 2016,the high-sensitivity cardiac troponin I assay reclassified 17 percent ofpatients with MI or myocardial injury who were not identified by the contemporary assay. [N Engl J Med 2018;doi: 10.1016/ S0140-6736(18)31996-2].
Among those reclassified, subsequent MI or cardiovascular death within 1 year occurred in 15 percent of patients in the validation phase vs. 12 percent in the implementation phase (odds ratio [OR], 1.10,95 percent confidence interval [CI], 0.75 to 1.61; P=0.620).
The validation phase was done for 6-12months with contemporary cardiac troponin I assay used as a guide for care. The subsequent implementation phase [early (n=5 hospitals) or late (n=5 hospitals)]involved testing patients with the high-sensitivity cardiac troponin I assay immediately or 6 months after the validation phase.
In the reclassified patients, there were also no differences in any secondary efficacy and safety outcome measuresbetween the validation and implementation phases, including all cause death (OR,0.71, 95 percent CI, 0.46 to 1.10), hospitalization for heart failure (OR,1.34, 95 percent CI, 0.84 to 2.16) and ischaemic stroke (OR, 0.85, 95 percent CI, 0.33 to 2.18).
“The trial found that implementation of a high-sensitivity cardiac troponin I assay using the 99th centile as the diagnostic threshold increased the frequency of diagnosing MI. However, use of this method to help diagnose and treat patients was not associated with lower rates of recurrent MI or cardiovascular death in 1 year,” said investigator Professor Nicholas Mills from the University of Edinburgh, UK.
“Among those reclassified, around one-third was diagnosed with type I MI, where treatment guidelines are still lacking.Also, a majority of the reclassifyed patients were females, where the effectiveness of treatment modalities has not been tested widely,” Mills further commented.
“In the study, sampling and treatment protocols were not according to ESC guidelines, and patients with renal failure, myocarditis, and type 2 MI were included. These probably resulted in ‘dilution’ of outcome results,”said discussant Professor Christian Hamm from the University of Glessen, Germany.
The High-STEACS trial is the first randomized trial to evaluate whether the introduction of a high-sensitivity cardiac troponin I assay with a 99th centile diagnostic threshold would reduce subsequent MI or cardiovascular death at 1 year among patients suspected to have acute coronary syndrome. According to the universal definition of MI, any increase in cardiac troponin above the 99th centile of a healthy reference population should be used as one of the diagnostic criteria for MI. [Eur Heart J 2018, doi: 10.1093/eurheartj/ehy462].
欲知更多医药信息,请登录MIMS.com
免费下载MIMS应用程序!
很赞哦! ()
相关文章
- 山东医药代理商资料:口腔医疗市场进入高增长状态 市场行情将迎黄金时代
- 医药耗材招商代理网:气血康口服液价格是多少 有效果吗
- 临床药品招商流程:三分钟医药新闻早餐 医药业首发税收指南
- 开医药代理公司多少钱:国务院财政部发文 将取消28项药品进口关税
- 药品招商的演讲:AiCuris公司公布乙肝功能性治愈疗法ACI649的首个人体单次剂
- 提高女性性欲药品招商:中药材科普之牛白藤
- 药品精准招商的手段:儿科本科停招17年 儿科医生缺口20万!
- 药品招商 杂志:2017年两会“吹风”,关注五大医药看点
- 药品招商问题反馈与建议:三喜临门!3款重磅新药分别在中美获批临床
- 医药品种代理:药价中的政策深思 降价应否一视同仁?
- 医药代理和医药销售额:医用美白祛斑面膜贴牌代加工
- 招商国证生物医药指数基金:研究认为:提高药品质量应关注九大关键因素
- 药品地总代理市场控销协议:难降药价之高, “两票制”何时换汤又换药
- 招商银行医药股票基金:美国FDA授予阿斯利康新型抗炎药Fasenra(benralizumab)治
- 招商医药健康产业基金好吗:把握“三新”?推动我国向医药创新强国转变
- 山东省医药招商招聘:白癜风可以使用扁白代用茶吗
- 医药招商经理医院开发:福莱思退热贴适不适合小孩使用
- 医药招商挣钱吗:照只能用来“晒”?不,还能诊断罕见基因病
- 医药招商促销活动:季德胜蛇药片说明书
- 药品招商经理规划书:MAH制度试点让企业尝到了哪些“甜头”?
- 药脉通上的药品代理:闽持续推进医改 进一步完善基药制度
- 医药产业 招商引资 问题:新版医保目录8月来袭 这四类药调入呼声最高
- 医药招商与自营的区别:孩子用药甜味型最好防治药物搭配不科学
- 独家代理药品都有哪些:颠茄片-(海外制药(华电)有限公司)
- 代理药品工资待遇怎么样:西红柿10大养生功效 防癌抗衰降压
- 药品招商遇到瓶颈:“供过于求”的药品注册申请将受限制
- 药品招商杜记独角膏:从消费升级看DR发展历程
- 略阳医药代理:卫生院升级、非基药“解禁”…基层市场“春天到了”?
- 最新推出的医药招商:女人激光祛斑后会反弹更严重吗 反弹的原因有哪些_美容护
- 宁乡医药代理招聘信息:医药招商的原则是什么
随机图文
专家警告地塞米松或面临全球短缺
但事实上,根据美国药师协会的报告,在牛津大学的这项研究成果发布之前,美国境内就已出现静脉注射用地倒计时!这些品种调出医保
米内网数据显示,在37个超10亿的地方医保产品中,有14个被纳入了国家重点监控目录——包括胸腺五肽、好品牌,手续票齐全,适合炒作、院外
专业供应商,专注膏药十六年,全新中药配方,融合温灸透皮技术,易吸收,无刺激,无残留,效果出众,新模扁鹊耳聋丸,独家爆款,长线产品,抢到
4、有视频广告,多重手段保证你快速占领市场!6、错过了“甘博士通窍耳聋丸”,现在抓住机会也不晚!罗销售这类口罩 医药人被判15年
据国家市监局官网消息,近日重庆市市场监管局、市发改委、市经信委、市公安局等7部门联合对防疫物如何管理连锁药店滞销品
对于我们连锁药店来说,在经营过程中,大家最值得关心和关注的应该是商品的动销,因为不管你商品规划的医保乙类、抗焦虑抑郁药——氟哌
通用名:氟哌噻吨美利曲辛片 规格包装:0.5mg:10mg*20s 用法用量:成人SCIENCE:运动可以改善阿尔茨海默
MIMS医药资讯:gh_260ce2309fff-SCIENCE:运动可以改善阿尔茨海默病小鼠的认知高敏肌钙蛋白检测并不能改善急性
MIMS医药资讯:gh_260ce2309fff-高敏肌钙蛋白检测并不能改善急性心梗患者的预后医保局、卫健委关于推进新冠肺炎
MIMS医药资讯:gh_260ce2309fff-医保局、卫健委关于推进新冠肺炎疫情防控期间开展“互联网+”医保卫健委印发《新型冠状病毒肺炎诊
MIMS医药资讯:gh_260ce2309fff-卫健委印发《新型冠状病毒肺炎诊疗方案(试行第七版)》通过美国食品药品管理局新药审批
MIMS医药资讯:gh_260ce2309fff-通过美国食品药品管理局新药审批的药物(2020年2月)